Drug Type Small molecule drug |
Synonyms Dapagliflozin thioglucoside analogue |
Target |
Action inhibitors |
Mechanism SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC21H25ClO6S |
InChIKeyZLLOUMFUWPPHRL-RQXATKFSSA-N |
CAS Registry2952941-12-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Discovery | China | 22 Aug 2023 |